Delivering Third-Party Liability Results, Mile After Mile
UMass Experts Talk About Where Medicaid Might Be Headed
How We Solve Medicaid Challenges
UMass Chan Medical School helps states navigate their high-priority challenges, by offering specialized services and expertise to contain costs and improve outcomes. Our offerings address the following:
- An increased focus on developing new service delivery and financing models
- The importance of federal waivers in securing programmatic funding
- Long-term services and supports challenges for Medicaid enrollees with complex needs
- Supporting Medicaid as the Payer of Last Resort
Medicaid Consulting and Operations
Financing and claiming initiatives
Helping states recover significant costs and save millions
Policy design and development
Developing, evaluating, and implementing targeted health care policies
Drug management strategies for high-cost medications
Curbing medication costs while improving treatment outcomes
Delivery System and Payment Reform
Federal approval for waivers
Navigating the waiver process from start to finish
Alternative payment systems
Helping develop shared savings arrangements, bundled payments, and global payments
Payment method modeling
Evaluating how reimbursement and purchasing reforms affect financing and service delivery
Long-Term Services and Supports
Data analytics
Providing a complete picture of a complex population
Complex clinical case consultation
Ensuring Medicaid members receive the most appropriate and highest quality care
Disability determinations
Providing medical and vocational reviews of disability cases
Medication therapy management
Optimizing medication use and enhancing CMS star ratings
Medicare Eligibility Enhancement
Medicare and disability entitlement correction
Resolving federal errors to increase individual benefits and state savings
Medicare outreach and enrollment
Increasing Medicare enrollment for eligible Medicaid recipients
Medicare Premium Payment Review
Integrating state and federal data to ensure accurate state Medicare buy-in expenditures